Zimmerman Brittney S, Seidman Danielle, Berger Natalie, Cascetta Krystal P, Nezolosky Michelle, Trlica Kara, Ryncarz Alisa, Keeton Caitlin, Moshier Erin, Tiersten Amy
Department of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
J Breast Cancer. 2020 Oct;23(5):542-552. doi: 10.4048/jbc.2020.23.e56.
Prior to the coronavirus disease 2019 (COVID-19) pandemic, telehealth was rarely utilized for oncologic care in metropolitan areas. Our large New York City based outpatient breast/gynecologic cancer clinic administered an 18-question survey to patients from March to June 2020, to assess the perceptions of the utility of telehealth medicine. Of the 622 patients, 215 (35%) completed the survey, and of the 215 respondents, 74 (35%) had participated in a telehealth visit. We evaluated the use of telehealth services using the validated Service User Technology Acceptability Questionnaire. Sixty-eight patients (92%) reported that telehealth services saved them time, 54 (73%) reported telehealth increased access to care, and 58 (82%) reported telehealth improved their health. Overall, 67 (92%) of patients expressed satisfaction with the use of telehealth services for oncologic care during the COVID-19 pandemic. Telehealth services should be carefully adopted as an addition to in-person clinical care of patients with cancer.
在2019冠状病毒病(COVID-19)大流行之前,远程医疗在大都市地区的肿瘤护理中很少被使用。我们位于纽约市的大型门诊乳腺/妇科癌症诊所于2020年3月至6月对患者进行了一项包含18个问题的调查,以评估对远程医疗效用的看法。在622名患者中,215名(35%)完成了调查,在215名受访者中,74名(35%)曾参与过远程医疗就诊。我们使用经过验证的服务用户技术可接受性问卷评估了远程医疗服务的使用情况。68名患者(92%)报告称远程医疗服务节省了他们的时间,54名(73%)报告称远程医疗增加了获得护理的机会,58名(82%)报告称远程医疗改善了他们的健康状况。总体而言,67名(92%)患者对在COVID-19大流行期间使用远程医疗服务进行肿瘤护理表示满意。应谨慎采用远程医疗服务作为癌症患者面对面临床护理的补充。
Telemed J E Health. 2023-8
JAMA Netw Open. 2021-1-4
Am J Obstet Gynecol MFM. 2021-11
Gynecol Oncol Rep. 2024-10-12
Gynecol Oncol Rep. 2024-4-23
J Patient Rep Outcomes. 2023-12-1
Ecancermedicalscience. 2020-6-17
Clin Oncol (R Coll Radiol). 2020-6
J Chin Med Assoc. 2020-3
Lancet Oncol. 2020-3
N Engl J Med. 2020-1-24
JMIR Hum Factors. 2018-12-21